Dow Jones Top Company Headlines at 3 AM ET: Sanofi Multiple Sclerosis Drug Hit by Double Setback | China ...

Dow Jones12-15

Sanofi Multiple Sclerosis Drug Hit by Double Setback

A U.S. regulatory decision on tolebrutinib will again be delayed while a late-stage trial of the drug for a different form of the disease didn't hit its main goal.

----

China Vanke Shares Fall After Bondholders Reject Debt Extension Proposal

The property developer said it will hold a bondholder meeting on Thursday to discuss next steps.

----

Danske Bank Completes U.S. Justice Department Probation Period

Chief Executive Carsten Egeriis said formal processes in relation to the non-resident portfolio at Danske Bank's former Estonia branch have been finalized.

----

Roomba Maker Declares Bankruptcy, but Tries to Ease 'Bricking' Fears

iRobot says that customer service and app functionality won't be disrupted despite the restructuring.

----

Transportation Stocks Are Hitting Their Stride. That's a Good Sign for Investors.

Uncertainty over the labor market and tariffs will put the Dow Theory to the test in 2026.

----

SpaceX Starts a Wall Street Bake-Off to Hire Banks for Possible IPO

The rocket-and-satellite maker will interview bankers this week to advise it on its initial public offering

----

OpenAI Ends 'Vesting Cliff' for New Employees in Compensation-Policy Change

The ChatGPT maker and its competitor xAI have relaxed restrictions meant to keep new hires from leaving in the midst of a fierce talent war

----

Tonka Trucks Gambled on Keeping Production in China and Survived-Barely

Disrupted shipments shrank profits as the company that sells the toys to U.S. retailers awaited the outcome of trade talks.

----

CEOs to Keep Spending on AI, Despite Spotty Returns

Teneo's annual survey finds 68% of chief executives plan to increase AI spending in 2026.

----

The Publicity War Between AT&T and T-Mobile Is Getting Ugly

AT&T, T-Mobile US and Verizon are escalating their usual claims about whose wireless service is best with the launch of explicit customer poaching efforts and litigation.

----

A Chubb/AIG Deal Could Be Good for Shareholders and a Coup for Greenberg Family

Whether a deal happens is speculative at this point, but Wall Street appears to like the idea.

----

SolGold Board Backs Jiangxi Copper's Sweetened Takeover Bid

The Chinese state-owned miner has won the support of SolGold's board after making a revised bid that values U.K.-listed company at $1.13 billion

----

Lululemon Stock Surges on CEO Shift. Why Investors Are Cheering the Change.

Some analysts think Calvin McDonald's departure paves the way for a pivot for the beleaguered activewear company, and its stock.

----

The Highflying Hedge Fund With a Habit of Giving Investors IOUs

Despite decent performance, Armistice Capital plans to give clients shares in a new investment vehicle in lieu of cash for the fourth time in two years.

----

Trump's OK of AI Chip Sales in China Called 'Dangerous' by Senate Democrats

Sens. Elizabeth Warren, Chuck Schumer and other lawmakers said allowing sales of Nvidia's H200 processors in China undoes past U.S. containment efforts

----

Bank of America Shares Finally Recover From 2008 Financial Crisis

The bank's stock closed at $55.14, its first record since November 2006

 

(END) Dow Jones Newswires

December 15, 2025 03:00 ET (08:00 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment